AbbVie Calls Hepatitis C Drug Results 'Promising'

The pharmaceutical company said its late-stage clinical study of an all-oral treatment for hepatitis C backed up previously reported AbbVie data.



from WSJ.com: US Business http://ift.tt/1dSp6Eb

via IFTTT